Intensive breast screening in BRCA2 mutation carriers is associated with reduced breast cancer specific and all cause mortality
Crossref DOI link: https://doi.org/10.1186/s13053-016-0048-3
Published Online: 2016-04-14
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Evans, D. G.
Harkness, E. F.
Howell, A.
Wilson, M.
Hurley, E.
Holmen, M. M.
Tharmaratnam, K. U.
Hagen, A. I.
Lim, Y.
Maxwell, A. J.
Moller, P.
Funding for this research was provided by:
Medical Research Council (G960413)
License valid from 2016-04-14